Top Company News of the Day: Twitter, Meta, Amazon, Pfizer

Twitter’s Challenges Heat Up as Meta Prepares Rival App

The new threat comes as Elon Musk’s company offered further explanation for its controversial cap on how many tweets users can see.

Amazon Rolls Out Rivian’s Electric Vans in Europe

The tech giant said more than 300 electric delivery vehicles will be rolled out across Germany in the coming weeks. It plans to have 100,000 on the road globally by 2030.

Pfizer Taps Samsung Biologics in $900 Million Manufacturing Deal

Pfizer will look to the biotech arm of Samsung to manufacture biosimilar products ranging from oncology to immunotherapy.

Facebook Faces Fresh Threat to Sending Personalized Ads in EU

The surprise ruling could short-circuit the platform’s legal efforts to protect its ad-based business model on the continent.

SoftBank’s Son Envisions AI Eventually Being Used in Every Industry

SoftBank Group Chief Executive Masayoshi Son said artificial intelligence would be overwhelmingly smarter than the human brain and could eventually be used in any industry.

China’s Chip Industry Braces for Further Sanctions With Concerns and Defiance

At an annual semiconductor-industry conference in Shanghai, U.S. export restrictions are a major topic.

Crypto Giant Binance Struggles in Europe

The Netherlands and Belgium have barred the exchange, Germany hasn’t given it a license to operate and French prosecutors are investigating it.

Zuckerberg Looks to Deliver Hit to Musk With Upcoming Twitter Clone Named Threads

The planned Meta microblogging app, set for release Thursday, is seen as a potential rival because of the Instagram connection and the company’s history.

What Is Spill? The Twitter Alternative Trending After Elon Musk Set User Limits

Designed by former Twitter employees, the app has attracted users including Questlove and garnered interest from Lizzo.

J2 Ventures Collects $69 Million Toward Fund for Civilian, Government Tech

Boston-based firm helps healthcare and tech startups get funding and contracts from federal agencies-a source of support as investment and acquisitions remain otherwise torpid.

Source: Dow Jones Newswires


Posted

in

by

Tags: